-
公开(公告)号：EP3489260B1
公开(公告)日：2020-12-02
申请号：EP19150601.3
申请日：2008-02-22
-
2.发明授权AGENTS THAT ENGAGE ANTIGEN - PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC- ASGPR) 有权活化的抗原呈递细胞的活性成分BY去唾液酸糖蛋白的树突状细胞的受体（DC ASGPR）
公开(公告)号：EP2115129B1
公开(公告)日：2013-11-13
申请号：EP08714180.0
申请日：2008-02-02
CPC分类号： A61K39/145 , A61K47/6849 , A61K51/1027 , A61K2039/5154 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C07K16/28 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/74 , C07K2317/75 , C07K2317/92 , C12N5/0639 , C12N7/00 , C12N2760/16122 , C12N2760/16134 , Y02A50/472
摘要： The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
摘要翻译： 本发明包括组合物和方法用于制备和使用抗DC抗体也可以ASGPR，E. G.，激活的DC和其它细胞。
-
3.发明公开ACTIVATION OF HUMAN ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL LECTIN-LIKE OXIDIZED LDL RECEPTOR-1 (LOX-1) 审中-公开通过凝集素样受体氧化LDL-1（LOX-1）的树突细胞的人抗原呈递细胞的活化
公开(公告)号：EP2132226A2
公开(公告)日：2009-12-16
申请号：EP08730569.4
申请日：2008-02-22
CPC分类号： C07K16/28 , A61K2039/5154 , A61K2039/55516 , C07K2317/92 , C07K2319/01 , C07K2319/33
摘要： The present invention includes compositions and methods for targeting the LOX-1 receptor on immune cells and uses for the anti-LOX-1 antibodies.
-
4.发明公开AGENTS THAT ENGAGE ANTIGEN - PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC- ASGPR) 有权活化的抗原呈递细胞的活性成分BY去唾液酸糖蛋白的树突状细胞的受体（DC ASGPR）
公开(公告)号：EP2115129A2
公开(公告)日：2009-11-11
申请号：EP08714180.0
申请日：2008-02-02
CPC分类号： A61K39/145 , A61K47/6849 , A61K51/1027 , A61K2039/5154 , C07K14/005 , C07K14/195 , C07K14/37 , C07K14/405 , C07K14/435 , C07K16/28 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/74 , C07K2317/75 , C07K2317/92 , C12N5/0639 , C12N7/00 , C12N2760/16122 , C12N2760/16134 , Y02A50/472
摘要： The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
-
5.发明公开
公开(公告)号：EP3489260A1
公开(公告)日：2019-05-29
申请号：EP19150601.3
申请日：2008-02-22
摘要： The present invention includes compositions and methods for targeting the LOX-1 receptor on immune cells and uses for the anti-LOX-1 antibodies.
-
公开(公告)号：EP2132226B1
公开(公告)日：2019-03-27
申请号：EP08730569.4
申请日：2008-02-22
-
公开(公告)号：EP2129692A2
公开(公告)日：2009-12-09
申请号：EP08743530.1
申请日：2008-02-22
IPC分类号： C07K17/14
CPC分类号： C07K16/2851 , C07K2317/56 , C07K2317/74 , C07K2317/75
摘要： The present invention includes compositions and methods for using novel anti-CLEC-6 antibodies and fragments thereof for modulating the activity of immune cells.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.018 秒)
